Cargando…
Binding of urokinase to specific receptor sites on human breast cancer membranes.
The high molecular weight form of the plasminogen activator urokinase (54 kD) binds to specific receptor sites on the cell membrane of breast carcinomas by its inactive "A" chain. The binding is of high affinity (range of dissociation constants: 5.6 X 10(-11) to 4 X 10(-10) mol l-1 and the...
Autores principales: | Needham, G. K., Sherbet, G. V., Farndon, J. R., Harris, A. L. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1987
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2001562/ https://www.ncbi.nlm.nih.gov/pubmed/3028459 |
Ejemplares similares
-
Possible surface protein markers for breast cancer.
por: Wildridge, M., et al.
Publicado: (1981) -
A cellular binding site for the Mr 55,000 form of the human plasminogen activator, urokinase
Publicado: (1985) -
Three types of human lung tumour cell lines can be distinguished according to surface expression of endogenous urokinase and their capacity to bind exogenous urokinase.
por: Schwartz-Albiez, R., et al.
Publicado: (1992) -
Epidermal Growth Factor Receptors and Breast Cancer
por: Farndon, J. R., et al.
Publicado: (1989) -
Negative regulation of urokinase receptor activity by a GPI-specific phospholipase C in breast cancer cells
por: van Veen, Michiel, et al.
Publicado: (2017)